Joint Formulary & PAD

Levosimendan - Heart failure

You are here : Home > Formulary Search > Levosimendan - Heart failure

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Levosimendan
Indication :
Heart failure
Group Name :
Keywords :
acutely decompensated heart failure
Brand Names Include :
Important Information :
Acutely decompensated heart failure. Unlicensed. Restricted to cardiology / ICU only. Use according to protocol
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Heart failure
Supporting Documents :
0

Committee Recommendations (1)

04 Sep 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Levosimendan is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Heart failure.